Dr. Benjamin J. Koestler's lab at Western Michigan University studies how bacteria survive acidic environments, particularly focusing on E. coli and Shigella. His team investigates the role of amino acids in helping these bacteria resist acid stress and the regulatory mechanisms involved, particularly the second messenger c-di-GMP. Their research has implications for human health as it aims to uncover new strategies to promote beneficial bacteria and mitigate harmful pathogens in our gastrointestinal systems.

Dr. Stacey Gilk's lab focuses on understanding how the bacterium Coxiella burnetii survives and thrives in acidic environments within infected human cells. This research is crucial for developing new treatments for Q fever, a disease caused by this pathogen, which can lead to severe health issues. By investigating the mechanisms that allow this bacteria to regulate its internal pH and survive under stress, the lab aims to identify potential new therapeutic targets for chronic infections.

Dr. Jolanta Grembecka's lab at the University of Michigan focuses on developing new therapies for acute leukemia, particularly targeting proteins involved in the disease's development. Their research aims to create small molecule inhibitors that can disrupt key interactions, helping to halt the progression of leukemias characterized by specific genetic mutations. This work is vital in improving survival rates for leukemia patients who currently have limited treatment options.

Xianxin Hua's research lab at the University of Pennsylvania focuses on developing innovative immunotherapies for treating acute myeloid leukemia (AML). The lab is particularly interested in creating CAR T cells that target specific proteins on AML cells to improve treatment effectiveness while minimizing damage to healthy cells. Their work aims to translate new findings into clinical applications to offer better therapeutic options for patients with refractory AML.

Niels Ringstad's research lab at NYU focuses on discovering new treatments for addiction by studying natural compounds from microbes that can influence brain signaling. Using a microscopic worm called C. elegans, the lab explores how these compounds affect specific neurotransmitter systems involved in addiction. Their work aims to identify novel small molecules that can better regulate neurochemical pathways linked to human behavior and impulse control.

Dr. Zach Adelman's lab at Texas A&M Agrilife Research focuses on innovative genetic engineering strategies to control mosquito populations that transmit diseases like dengue, yellow fever, and chikungunya. The lab explores how gene editing tools like CRISPR can be used to insert or remove genes from mosquitoes, improving efforts to develop safer and more effective mosquito control methods. Their research has the potential to significantly impact public health by making gene drive technologies more reliable and manageable.

Dr. Jason T. Kaelber's lab at Rutgers focuses on improving gene therapies that use adeno-associated viruses (AAV). They are exploring the detailed mechanisms of how these viruses infect cells and package their genetic material, which could lead to more effective therapies with fewer side effects. By applying advanced imaging techniques, the lab aims to directly visualize viral interactions at the molecular level to address the challenges associated with AAV gene therapy.

Dr. Silvia Corvera's lab focuses on understanding how human adipose (fat) tissue regulates metabolism and energy balance, especially in the context of diseases like Type 2 Diabetes. By studying the activities of different types of human fat cells in laboratory models, they aim to uncover the mechanisms that control fat storage and energy expenditure, which are crucial for preventing metabolic disorders. Their groundbreaking research includes techniques to develop functional human fat in mice, allowing for innovative studies on fat cell behavior and the effects of specific genes on metabolism.

Dr. Michael Stowell's lab at the University of Colorado focuses on developing advanced imaging technologies to better understand the dynamic structures of biological molecules. They create systems that improve cryogenic electron microscopy, allowing scientists to capture the changing nature of proteins and other complex biological systems over time. This research aims to shed light on how these structures influence health and disease, paving the way for new therapies.

The lab led by Liou Sun at the University of Alabama at Birmingham focuses on understanding the role of ceramide signaling in aging and age-related diseases. By using mouse models, the lab investigates how growth hormone deficiency impacts longevity and healthspan. Their work aims to uncover potential therapeutic interventions that could improve health during aging and combat diseases associated with aging, like tauopathies.

Dr. Colleen K. Jackson-Cook's lab at Virginia Commonwealth University focuses on understanding how aging affects our cells at a genetic level. They conduct a long-term study on twins to explore how genetics and environment influence the presence of cytosolic DNA, which may play a role in age-related health issues. By analyzing how this DNA interacts with other biological markers of aging, the lab aims to uncover potential treatments for age-related diseases.

The research lab led by Dr. Vera Gorbunova at the University of Rochester focuses on understanding the aging process and strategies to maintain genomic stability in cells. They investigate how certain genes, particularly Sirtuin 6, influence lifespan and epigenetic rejuvenation, and use comparative genomics to explore longevity mechanisms in various animal species. The goal is to apply these insights to prevent age-related diseases such as Alzheimer's.

Dr. Shusheng Wang's lab at Tulane University focuses on studying the effects of aging and cigarette smoke on the retinal pigment epithelium (RPE) and its role in age-related macular degeneration (AMD). They investigate how mitochondrial dysfunction induced by these factors can lead to different RPE phenotypes, potentially contributing to the disease. The lab aims to understand the mechanisms driving this heterogeneity and to identify potential therapeutic targets for treating dry AMD.

Dr. Susan L. Swain's lab at the University of Massachusetts Medical School focuses on understanding how aging affects the immune response to influenza. The research particularly examines a unique population of B cells that may help protect older adults from flu infections. By studying how these cells respond to different types of vaccines, the lab aims to improve vaccine efficacy for the elderly, who are particularly vulnerable to flu and other viruses like COVID-19.

Dr. Stanislava Chtarbanova's lab focuses on understanding how aging affects the interactions between hosts and viruses, particularly in older adults who are more vulnerable to infections. Using the fruit fly Drosophila melanogaster as a model, her team investigates the genetic and metabolic mechanisms that contribute to survival from viral infections and how these infections evolve within older hosts. The goal is to uncover insights that could lead to better treatments for elderly patients and prevent the emergence of new viral strains.

Dr. Daniel Gorelick's lab at Baylor College of Medicine studies how environmental pollutants like dioxins and polycyclic aromatic hydrocarbons (PAHs) affect health by interacting with proteins in our cells. They focus on a specific protein called the aryl hydrocarbon receptor (AHR) that regulates gene expression in response to these toxic substances. By exploring the complexities of AHR signaling, the lab aims to uncover new insights into how these pollutants can lead to diseases, thereby improving our understanding of their impact on human health.

Dr. Wei Wang’s lab at UC San Diego focuses on cutting-edge research combining artificial intelligence and molecular biology to explore innovative solutions for anti-aging therapies and genetic disease. The first major project aims to develop advanced AI models for designing antibodies that can rejuvenate the immune system, ultimately improving life quality in aging populations. The second project investigates the role of non-coding DNA regions in cellular functions and disease, aiming to uncover how mutations in these regions affect health and could lead to new therapeutic approaches.

Dr. John G. Albeck's lab at UC Davis focuses on understanding how individual cells manage their metabolism, particularly through glycolysis, the process by which glucose is broken down for energy. They use advanced live-cell measurements to explore how different cells in tissues like muscle and liver can vary in their metabolic activities. This research aims to unveil the links between metabolism and other cell functions, such as growth and death, which could lead to new insights into diseases like diabetes and cancer.

Dr. Gowthaman Uthaman's lab at the University of Massachusetts Medical School focuses on understanding how specific immune cells contribute to allergenic responses in the body. The research particularly investigates a novel type of T helper cell, called Tfh13 cells, which are vital in producing IgE antibodies responsible for dangerous allergic reactions. By studying these cells, the lab aims to discover new ways to prevent or treat severe allergies and anaphylaxis.

Dr. Jose Manuel Alonso's lab studies how our eyes process visual information, focusing specifically on two pathways that detect light and dark signals. Their research aims to understand how these pathways function in different lighting conditions, particularly in relation to myopia, a condition that causes blurred distance vision. By investigating neuronal responses with innovative techniques, the lab hopes to develop new strategies for preventing and treating myopia.